Cell Line Authentication and Characterization Tests Market Size [2031]
Cell Line Authentication and Characterization Tests Market Size [2031]
Segments - Cell Line Authentication and Characterization Tests Market by Type (Short Tandem Repeat Analysis, Karyotype, Single Nucleotide Polymorphism Analysis, and Others), Application (Cell Line Identity, Microbial Contamination, Virus Testing, Genetic Stability, and Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5699
| 4.6 Rating
| 56 Reviews
| 189 Pages
| Format :
Report Description
Cell Line Authentication and Characterization Tests Market Outlook 2031
The global cell line authentication and characterization tests market size was USD 365.7 Million in 2022 and is likely to reach USD 743.3 Million by 2031, expanding at a CAGR of 8.2% during 2023–2031. The market growth is attributed to the rising geriatric population and growing technological advancement.
Growing advancements in biotechnology are anticipated to significantly contribute to the growth of the cell line authentication and characterization tests market. Increasing investment in research and development has shifted the focus toward personalized medicine. This leads to an increasing demand for authentication services.
Cell line authentication and characterization testing involve a series of processes to confirm the identity of cell strains and ensure they are devoid of microbial and other contaminants. This testing is crucial for maintaining biological safety standards. Validating the authenticity of cell lines is a vital step in upholding the reliability and credibility of biomedical research.
Contaminants in cell cultures include bacteria, viruses, fungi, as well as unwanted cell lines from same or different species. These impurities significantly alter the behavior and characteristics of cells potentially compromising the accuracy of experimental results. Additionally, the increasing demand for precise qualitative and quantitative analysis of cell lines is expected to propel the market in the forecasted period.
The market report finds that the COVID-19 pandemic hampers the cell line authentication and characterization tests market. The pandemic led to disruptions in global supply chains. This affected the availability of reagents, consumables, and equipment used in cell line authentication and characterization tests. Many research institutions and companies shifted their focus towards research and development (R&D) related to COVID-19. This diverted resources and attention away from other areas of biomedical research which slowed down the demand for cell line authentication and characterization tests.
Cell Line Authentication and Characterization Tests Market Dynamics
Major Drivers
Rising incidence of chronic disease drives the market. Geriatric populations are more likely to develop chronic diseases such as cancer, cardiovascular conditions, and neurodegenerative disorders. These conditions often require extensive biomedical research and drug development efforts. Dependable cell line authentication and characterization tests are crucial in this process to ensure accurate results.
Existing Restraints
Limited awareness and education for cell line authentication and characterization tests is expected to hamper the market. Researchers who are not well-informed about cell line authentication may underestimate its critical role in ensuring the reliability of experimental results. Without proper education, researchers cannot realize the risks associated with using contaminated cell lines. This leads to a lower demand for authentication services.
Emerging Opportunities
Growing advancement in cell therapies creates lucrative opportunities for the market. The field of cell-based therapies including treatments using stem cells, immune cells, and other specialized cells, is rapidly expanding. These therapies hold the potential for treating a wide range of diseases and conditions. Cell line authentication and characterization are crucial steps in the development and production of cell-based therapies. This step ensures the accurate identification, purity, and properties of the cell lines, which is essential for the safety and efficacy of these advanced treatments.
Scope of the Cell Line Authentication and Characterization Tests Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cell Line Authentication and Characterization Tests Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Short Tandem Repeat Analysis, Karyotype, Single Nucleotide Polymorphism Analysis, and Others), Application (Cell Line Identity, Microbial Contamination, Virus Testing, Genetic Stability, and Others), and End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Microsynth AG; IDEXX Laboratories, Inc.; DNA Forensics Laboratory Pvt. Ltd.; Cell Line Genetics, Inc.; GenomeScan; Merck KGaA; Forge Biologics; Bio-Synthesis; Laboratory Corporation of America Holdings; Thermo Fisher Scientific Inc.; Perfectus Biomed Limited; and Charles River Laboratories. |
Cell Line Authentication and Characterization Tests Market Segment Insights
Type Segment Analysis
Based on type, the cell line authentication and characterization tests market is divided into short tandem repeat analysis, karyotype, single nucleotide polymorphism analysis, and others. The short tandem repeat(STR) analysis segment holds the dominant share of the market during the projection period, as it provides a high level of accuracy.
STR is a widely adopted method in cell line authentication. It has a strong track record of success and is recognized by regulatory authorities, research institutions, and pharmaceutical companies as a reliable technique. STR analysis is known for its high accuracy in identifying and verifying specific DNA sequences. This makes it a preferred method for authenticating cell lines, as it accurately detects even minor genetic variations.
The single nucleotide polymorphism analysis segment is expected to expand at a significant growth rate in the coming years as it provides high specificity and increasing quality control in research. SNP analysis is a highly specific and sensitive method for characterizing and authenticating cell lines.
It involves the identification of single nucleotide variations in the DNA sequence which makes it a reliable tool to distinguish different cell lines with precision. Researchers and laboratories performing experiments or drug development studies rely on SNP analysis to ensure the quality of their cell lines. It helps in reducing the risk of contamination or misidentification.
Application Segment Analysis
On the basis of application, the global market is segregated into cell line identity, microbial contamination, virus testing, genetic stability, land others. The microbial contamination segment is projected to register a high CAGR during the forecast period, due to growing awareness of microbial contamination risk.
There is an increasing awareness among researchers and biopharmaceutical companies about the potential risks associated with microbial contamination in cell cultures. Contaminants such as bacteria, fungi, and viruses can significantly impact experimental results and compromise the truthfulness of research. This awareness is driving the demand for robust testing methods.
End-user Segment Analysis
On the basis of end-user, the cell line authentication and characterization tests market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies’ segment is expected to generate a major revenue share of the market, due to rising R&D activities.
Pharmaceutical and biotechnology industries are in the lead of biomedical research and development. They invest heavily in the discovery and production of new drugs, biologics, and therapies. Expanding these industries creates a higher demand for reliable cell line authentication and characterization tests to ensure the reliability of their research outcomes.
The academic & research institutes are anticipated to hold a significant share of the market, due to the growing education &training and rising government funding. Academic institutions play a pivotal role in training the next generation of scientists including researchers, clinicians, and biotechnologists. They require authenticated cell lines for educational purposes such as laboratory courses, thesis projects, and research training.
Many academic and research institutions receive government funding for scientific research projects. These grants often come with specific requirements for quality control measures. This drives the demand for testing services in these settings.
Regional Outlook
In terms of region, the global Cell Line Authentication and Characterization Tests market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the presence of advanced healthcare infrastructure.
North America has a highly advanced and well-established healthcare infrastructure. The region is recognized for superior research institutions, academic centers, and biotechnology hubs. This infrastructure provides a favorable environment for the development and adoption of sophisticated cell line authentication and characterization technologies.
The market in Asia Pacific is projected to grow rapidly during the forecast period, owing to the growing biotechnology & pharmaceutical industry and the academic & research landscape. The Asia Pacific witnessed significant growth in the biotechnology and pharmaceutical sectors. Emerging economies such as China, India, and South Korea have emerged as major hubs for research, development, and production in the life sciences industry.
Academic and research institutions are actively engaged in diverse fields of research including biotechnology, genomics, and pharmaceuticals. They heavily rely on accurate cell line authentication for their experiments and studies.
Segments
The cell line authentication and characterization tests market has been segmented on the basis of
Type
- Short Tandem Repeat Analysis
- Karyotype
- Single Nucleotide Polymorphism Analysis
- Others
Application
- Cell Line Identify
- Microbial Contamination
- Virus Testing
- Genetic Stability
- Virus Testing
- Others
End-user
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Microsynth AG
- IDEXX Laboratories, Inc.
- DNA Forensics Laboratory Pvt. Ltd.
- Cell Line Genetics, Inc.
- GenomeScan
- Merck KGaA
- Forge Biologics
- Bio-Synthesis
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- Perfectus Biomed Limited
- Charles River Laboratories
Competitive Landscape
Key players competing in the global cell line authentication and characterization tests market are Microsynth AG; IDEXX Laboratories, Inc.; DNA Forensics Laboratory Pvt. Ltd.; Cell Line Genetics, Inc.; GenomeScan; Merck KGaA; Forge Biologics; Bio-Synthesis; Laboratory Corporation of America Holdings; Thermo Fisher Scientific Inc.; Perfectus Biomed Limited; and Charles River Laboratories.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. For instance,
- In May 2023, Forge Biologics, a prominent manufacturer of genetic medicine collaborated with LabCorp for gene therapy development. Their strategic aim was to create greater accessibility to services for adeno-associated virus (AAV) mediated gene therapy programs.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell Line Authentication and Characterization Tests Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell Line Authentication and Characterization Tests Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell Line Authentication and Characterization Tests Market - Supply Chain
4.5. Global Cell Line Authentication and Characterization Tests Market Forecast
4.5.1. Cell Line Authentication and Characterization Tests Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell Line Authentication and Characterization Tests Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cell Line Authentication and Characterization Tests Market Absolute $ Opportunity
5. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
5.3.1. Short Tandem Repeat Analysis
5.3.2. Karyotype
5.3.3. Single Nucleotide Polymorphism Analysis
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
6.3.1. Cell Line Identify
6.3.2. Microbial Contamination
6.3.3. Virus Testing
6.3.4. Genetic Stability
6.3.5. Virus Testing
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
7.3.1. Academic & Research Institutes
7.3.2. Pharmaceutical & Biotechnology Companies
7.3.3. Others
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
9. North America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
9.4.1. Short Tandem Repeat Analysis
9.4.2. Karyotype
9.4.3. Single Nucleotide Polymorphism Analysis
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
9.7.1. Cell Line Identify
9.7.2. Microbial Contamination
9.7.3. Virus Testing
9.7.4. Genetic Stability
9.7.5. Virus Testing
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
9.10.1. Academic & Research Institutes
9.10.2. Pharmaceutical & Biotechnology Companies
9.10.3. Others
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
10. Latin America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
10.4.1. Short Tandem Repeat Analysis
10.4.2. Karyotype
10.4.3. Single Nucleotide Polymorphism Analysis
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
10.7.1. Cell Line Identify
10.7.2. Microbial Contamination
10.7.3. Virus Testing
10.7.4. Genetic Stability
10.7.5. Virus Testing
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
10.10.1. Academic & Research Institutes
10.10.2. Pharmaceutical & Biotechnology Companies
10.10.3. Others
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
11. Europe Cell Line Authentication and Characterization Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
11.4.1. Short Tandem Repeat Analysis
11.4.2. Karyotype
11.4.3. Single Nucleotide Polymorphism Analysis
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
11.7.1. Cell Line Identify
11.7.2. Microbial Contamination
11.7.3. Virus Testing
11.7.4. Genetic Stability
11.7.5. Virus Testing
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
11.10.1. Academic & Research Institutes
11.10.2. Pharmaceutical & Biotechnology Companies
11.10.3. Others
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
12. Asia Pacific Cell Line Authentication and Characterization Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
12.4.1. Short Tandem Repeat Analysis
12.4.2. Karyotype
12.4.3. Single Nucleotide Polymorphism Analysis
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
12.7.1. Cell Line Identify
12.7.2. Microbial Contamination
12.7.3. Virus Testing
12.7.4. Genetic Stability
12.7.5. Virus Testing
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
12.10.1. Academic & Research Institutes
12.10.2. Pharmaceutical & Biotechnology Companies
12.10.3. Others
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
13. Middle East & Africa Cell Line Authentication and Characterization Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Types
13.4.1. Short Tandem Repeat Analysis
13.4.2. Karyotype
13.4.3. Single Nucleotide Polymorphism Analysis
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by Applications
13.7.1. Cell Line Identify
13.7.2. Microbial Contamination
13.7.3. Virus Testing
13.7.4. Genetic Stability
13.7.5. Virus Testing
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa Cell Line Authentication and Characterization Tests Market Size and Volume Forecast by End Users
13.10.1. Academic & Research Institutes
13.10.2. Pharmaceutical & Biotechnology Companies
13.10.3. Others
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa Cell Line Authentication and Characterization Tests Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global Cell Line Authentication and Characterization Tests Market: Market Share Analysis
14.2. Cell Line Authentication and Characterization Tests Distributors and Customers
14.3. Cell Line Authentication and Characterization Tests Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. Microsynth AG
14.4.2. IDEXX Laboratories, Inc.
14.4.3. DNA Forensics Laboratory Pvt. Ltd.
14.4.4. Cell Line Genetics, Inc.
14.4.5. GenomeScan
14.4.6. Merck KGaA
14.4.7. Forge Biologics
14.4.8. Bio-Synthesis
14.4.9. Laboratory Corporation of America Holdings
14.4.10. Thermo Fisher Scientific Inc.
14.4.11. Perfectus Biomed Limited
14.4.12. Charles River Laboratories
Methodology
Related Reports
Some other reports from this category!
Our Clients
